|
|
|
|
|
Column
| Gentech: we know too little |
| |
I am often asked whether genetically modified food is really all that harmful. My answer is no. There is no evidence that it is dangerous, but as with almost all new developments, we know little about long-term effects. Some people think that because of this, our association wants all developments in this area to stop. Not true.
We do watch developments critically, because on the one hand we know that genetic modification is an important issue for consumers and that on the other hand we are not satisfied with how this matter is being dealt with. Up to sixty per cent of products containing soya and maize could be genetically modified – could, because no-one is sure. At present, manufacturers are usually not required to indicate this on the label.
We believe that thorough changes are needed, involving European legislation and related monitoring. Products must be tested objectively and labelling must be honest and clear. Only then does a consumer really have a choice. Currently, it is all about manufacturers. I think it is grievous that they are not focusing on creating consumer benefits, in the areas of price, taste or environment, for example. These benefits would give the discussion a whole new twist. Take a look at how new medicines are introduced to the market. The advantages for the user of a new medicine – whether genetically modified or not – must be scientifically established before it is introduced to the market. By definition, there are benefits for the consumer. The use of gentech is not controversial when it comes to drugs.
Felix Cohen is general director of the Consumentenbond (Dutch Consumer’s Association). His column was published in Cosun in Business, December 2001.<<< back
>>> more columns |
|
|
|
|
|